Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer

NCT00123851 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Neoplasm Metastasis

Interventions

DRUG: Tarceva (OSI-774)
DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]